A regression model including a Nocardia-treatment arm interaction found corticosteroid use associated with a mean 1-line improvement in BSCVA at 12 months among patients with non-Nocardia ulcers ( -0.10 logMAR , 95 % CI , -0.19 to -0.02 , P = .02 ) .